300888.SZ SHZ
Winner Medical Co., Ltd.
1W: -0.9%
1M: +1.0%
3M: +2.6%
YTD: -17.4%
1Y: -27.0%
3Y: -26.7%
5Y: -60.7%
¥29.25 ($4.36)
+0.37 (+1.28%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$18.4B
+7.5% ▲
5Y CAGR: +32.3%
Total Liabilities
$6.5B
+30.3% ▲
5Y CAGR: +36.6%
Shareholders Equity
$11.2B
-3.3% ▼
5Y CAGR: +28.7%
Cash & Investments
$4.7B
-38.1% ▼
5Y CAGR: +57.6%
Total Debt
$3.3B
+71.1% ▲
5Y CAGR: +66.3%
Net Debt
$1.9B
+187.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4.2B | $4.3B | $4.5B | $4.7B | $1.4B |
| Short-Term Investments | $4.1B | $3.1B | $4.4B | $2.9B | $3.3B |
| Cash & ST Investments | $8.3B | $7.4B | $8.9B | $7.6B | $4.7B |
| Net Receivables | $1.3B | $785M | $1.1B | $1.1B | $1.3B |
| Inventory | $1.2B | $1.6B | $1.6B | $1.4B | $2.0B |
| Other Current Assets | $617M | $508M | $483M | $383M | $33K |
| Total Current Assets | $11.0B | $10.3B | $12.1B | $10.6B | $8.1B |
| Property, Plant & Equip. | $1.5B | $2.2B | $3.6B | $4.3B | $5.2B |
| Goodwill & Intangibles | $208M | $266M | $2.1B | $1.9B | $2.3B |
| Long-Term Investments | -$4.1B | -$3.1B | -$4.3B | $134M | $2.5B |
| Other Non-Current Assets | $4.3B | $3.4B | $4.6B | $131M | $144M |
| Total Non-Current Assets | $2.0B | $2.9B | $6.1B | $6.6B | $10.6B |
| Total Assets | $13.0B | $13.3B | $18.2B | $17.1B | $18.4B |
| — Liabilities — | |||||
| Accounts Payable | $756M | $771M | $1.1B | $1.4B | $1.2B |
| Short-Term Debt | $150M | $0 | $2.3B | $1.5B | $2.8B |
| Deferred Revenue | $1.5B | $1.1B | $567M | $0 | $183M |
| Other Current Liabilities | -$743M | $240M | $276M | $1.3B | $747M |
| Total Current Liabilities | $2.4B | $2.1B | $5.5B | $4.3B | $5.3B |
| Long-Term Debt | $0 | $0 | $0 | $170M | $102M |
| Other Non-Current Liab. | -$269M | $0 | $9M | $130M | $387M |
| Total Non-Current Liabilities | $107M | $505M | $568M | $731M | $1.4B |
| Total Liabilities | $2.5B | $2.6B | $6.1B | $5.0B | $6.5B |
| — Equity — | |||||
| Common Stock | $426M | $426M | $426M | $594M | $582M |
| Retained Earnings | $5.1B | $5.5B | $6.8B | $6.6B | $6.8B |
| Accumulated OCI | $443M | $511M | $509M | $540M | $548M |
| Total Stockholders Equity | $10.5B | $10.7B | $11.7B | $11.5B | $11.2B |
| Total Liabilities & Equity | $13.0B | $13.3B | $18.2B | $17.1B | $18.4B |
| — Key Metrics — | |||||
| Total Debt | $150M | $598M | $2.8B | $2.0B | $3.3B |
| Net Debt | -$4.0B | -$3.7B | -$1.7B | -$2.2B | $1.9B |
| Total Investments | $13M | $17M | $62M | $3.0B | $5.7B |